French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Improving personalized cancer treatments and finding the best strategies to treat each patient relies on using new diagnostic technologies. Currently, for colorectal cancer, the methods used to decide who gets additional post-surgery treatment are suboptimal. Some patients get too much treatment, while others do not get enough. There is a new way to explore if there is any cancer left in a patient's body using circulating tumor DNA (ctDNA) detected in blood samples. This can help decide who needs more treatment after surgery. Even though many tests have been developed, it has yet to be determined which test performs best at relevant time points. The GUIDE.MRD consortium is a group of experts, including scientists, technology, and pharmaceutical companies. The consortium is working on creating a reliable standard for the ctDNA tests, validating their clinical utility, and collecting data to help decide on the best treatment for each patient. FRENCH-MRD-CRC is the French study of the european GUIDE.MRD project.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rak jelita grubego lub odbytnicy w stadium I-III
- •Wiek 18 lat lub więcej
- •Zaplanowana operacja chirurgiczna w celu usunięcia nowotworu
✗ Disqualifies
- •Dziedziczny rak jelita grubego związany z polipozą rodzinną lub zespołem Lyncha
- •Potwierdzenie przerzutów nowotworu na inne narządy
- •Złośliwości w polipach po ich usunięciu
- •Kobieta w ciąży lub karmiąca, lub w wieku rozrodczym bez chęci stosowania antykoncepcji
- •Brak ubezpieczenia zdrowotnego
- •Niemożność zrozumienia i podpisania zgody na uczestnictwo
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 18, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
CHU de Montpellier
Montpellier, France
Trial contact
Catherine ALIX-PANABIERES, PhD
Thomas BARDOL, M.D.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/19/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.